Updating the Brazilian Pharmacopoeia

Updating the Brazilian Pharmacopoeia

Anvisa’s Collegiate Board Resolution (RDC) 832, of December 11, 2023, updated the 6th edition of the Brazilian Pharmacopoeia, which came into force on January 2, 2024.

The companies have 180 days from the date the regulation comes into force to adapt their procedures. Read more here

If you need information and help with Strategic Advice for the Pharmaceutical, Health and Wellness Industry, ELS can certainly help with our services.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.